Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement
Sales	$ 884,671	$ 5,692	$ 886,243	$ 34,860
Cost of sales	537,517	13,988	539,421	34,861
Gross margin (deficit)	347,154	(8,296)	346,822	(1)
Operating expenses:
Selling, general and administrative	683,040	550,805	1,626,413	3,583,083
Research and development	36,634	93,268	43,027	101,890
Depreciation	4,117	3,500	11,117	10,500
Total operating expenses	723,791	647,573	1,680,557	3,695,473
Loss from operations	(376,637)	(655,869)	(1,333,735)	(3,695,474)
Other income (expense):
Interest expense	(692,518)	(465,311)	(1,811,033)	(1,728,367)
Gain (loss) on derivative liability	7,400,658	(513,535)	(9,667,930)	(354,442)
Gain (loss) on debt settlement	8,963	67,661	20,818	(470,480)
Total other income (expense)	6,717,103	(911,185)	(11,458,145)	(2,553,289)
Income (loss) before income taxes	$ 6,340,466	$ (1,567,054)	$ (12,791,880)	$ (6,248,763)
Provision for income taxes
Net income (loss)	$ 6,340,466	$ (1,567,054)	$ (12,791,880)	$ (6,248,763)
Net income (loss) per common share - basic and diluted	$ 0.02	$ (0.06)	$ (0.04)	$ (0.36)
Weighted average number of common shares outstanding - basic and diluted	372,504,281	25,635,511	293,341,151	17,238,381